Novartis and SustainAbility presented a webinar on December 11th as part of a series of conversations about the results and outcomes of Novartis’ 2017 Corporate Responsibility Materiality Assessment.
In this webinar we explored how corporate action on the Sustainable Development Goals (SDGs) is linked to and can be driven by corporate responsibility materiality assessments.
Robert G. Eccles, Professor of Management Practice at the Harvard Business School and Saïd Business School presented SDG and debated how business can and should contribute to the achievement of the global 2030 agenda. Denise Weger, Senior Manager Strategic Initiatives Global Health & Corporate Responsibility, Novartis, provided background of the materiality assessment and Kileken ole-MoiYoi, Head Strategy Global Health & Corporate Responsibility, Novartis, shared how Novartis advanced its global health agenda in light of the SDGs and materiality assessment.
For further information please visit the links below: